Heparin (heparin): Reviews and patient testimonials
Medication indications
Heparin (Mucous ) Injection BP
For the treatment of thrombo-embolic disorders such as deep vein thrombosis, acute arterial embolism or thrombosis, thrombophlebitis, pulmonary embolism and fat embolism.For prophylaxis against deep vein thrombosis and thrombo-embolic events in susceptible patients.For the prevention of clotting in the extracorporeal circuit during haemodialysis.Heparin 5,000 I.U./ml Solution for injection (with preservative)
- Prophylaxis of deep vein thrombosis and pulmonary embolism.
- Treatment of deep vein thrombosis and pulmonary embolism, unstable angina pectoris and acute peripheral arterial occlusion.
- Prophylaxis of mural thrombosis following myocardial infarction.
- In extracorporeal circulation and haemodialysis.
Heparin sodium 1,000 I.U./ml solution for injection or concentrate for solution for infusion (with preservative)
Treatment of deep vein thrombosis, pulmonary embolism, unstable angina pectoris and acute peripheral arterial occlusion. In extracorporeal circulation and haemodialysis.Heparin sodium 1,000 I.U./ml Solution for injection or concentrate for solution for infusion (without preservative)
Treatment of deep vein thrombosis, pulmonary embolism, unstable angina pectoris and acute peripheral arterial occlusion. In extracorporeal circulation and haemodialysis.Heparin Sodium 10 I.U/ml flushing solution for maintenance of patency of intravenous devices
Heparin is an anticoagulant and acts by potentiating the naturally occurring inhibitors of thrombin and factor X (Xa). Heparin Sodium 10 I.U./ml Flushing Solution is indicated in any clinical circumstances in which it is desired to maintain the patency of indwelling catheters/cannulae, attendant lines or heparin locks.Heparin sodium 10 IU/ml IV flush solution
To maintain the patency of in-dwelling intravenous lines. It is not recommended for therapeutic use.Heparin Sodium 100 I.U./ml flushing solution for maintenance of patency of intravenous devices (Wockhardt UK Ltd)
Heparin is an anticoagulant and acts by potentiating the naturally occurring inhibitors of thrombin and factor X (Xa). Heparin Sodium 100 I.U./ml Flushing Solution is indicated in any clinical circumstances in which it is desired to flush an intravenous catheter or cannula with a low concentration of heparin to ensure patency prior to administration of an intravenous injection.HEPARIN SODIUM 100 IU/ml I.V. FLUSH SOLUTION
To maintain the patency of in-dwelling intravenous lines. It is not recommended for therapeutic use.Heparin sodium 1000 IU/ml ampoule, solution for infusion
Treatment of thrombo-embolic disorders such as: deep vein thrombosis, acute arterial embolism or thrombosis, thrombophlebitis, pulmonary embolism, fat embolism.Prevention of clotting in the extracorporeal circuit during haemodialysis.Heparin sodium 25,000 I.U./ml solution for injection or concentrate for solution for infusion (with preservative)
Prophylaxis of deep vein thrombosis and pulmonary embolism Treatment of deep vein thrombosis, pulmonary embolism, unstable angina pectoris and acute peripheral arterial occlusion. Prophylaxis of mural thrombosis following myocardial infarction. In extracorporeal circulation and haemodialysis.Heparin sodium 25,000 I.U./ml Solution for injection or concentrate for solution for infusion(without preservative)
Prophylaxis of deep vein thrombosis and pulmonary embolism Treatment of deep vein thrombosis, pulmonary embolism, unstable angina pectoris and acute peripheral arterial occlusion. Prophylaxis of mural thrombosis following myocardial infarction. In extracorporeal circulation and haemodialysis.Heparin Sodium 5,000 I.U./ml Solution for injection (without preservative)
- Prophylaxis of deep vein thrombosis and pulmonary embolism.
- Treatment of deep vein thrombosis and pulmonary embolism, unstable angina pectoris and acute peripheral arterial occlusion.
- Prophylaxis of mural thrombosis following myocardial infarction.
- In extracorporeal circulation and haemodialysis.
Heparin sodium 5,000 I.U./ml solution for injection or concentrate for solution for infusion (with preservative)
Prophylaxis of deep vein thrombosis and pulmonary embolism Treatment of deep vein thrombosis, pulmonary embolism, unstable angina pectoris and acute peripheral arterial occlusion. Prophylaxis of mural thrombosis following myocardial infarction. In extracorporeal circulation and haemodialysis.Heparin sodium 5,000 I.U./ml Solution for injection or concentrate for solution for infusion(without preservative)
Prophylaxis of deep vein thrombosis and pulmonary embolism Treatment of deep vein thrombosis, pulmonary embolism, unstable angina pectoris and acute peripheral arterial occlusion. Prophylaxis of mural thrombosis following myocardial infarction. In extracorporeal circulation and haemodialysis.Heparin Sodium BP 1000 IU/L in 0.9% w/v Sodium Chloride IV Infusion
Heparin sodium in 0.9% Sodium Chloride infusion is indicated as an anticoagulant in extra corporeal circulation and dialysis procedures, and as an aid in the maintenance of catheter patency.Heparin Sodium BP 2000 IU/L in 0.9% w/v Sodium Chloride IV Infusion
Heparin sodium in 0.9% Sodium Chloride infusion is indicated as an anticoagulant in extra corporeal circulation and dialysis procedures, and as an aid in the maintenance of catheter patency.Heparin Sodium BP 2500 IU/L in 0.9% w/v Sodium Chloride IV Infusion
Heparin sodium in 0.9% Sodium Chloride infusion is indicated as an anticoagulant in extra corporeal circulation and dialysis procedures, and as an aid in the maintenance of catheter patency.Heparin Sodium BP 5000 IU/L in 0.9% w/v Sodium Chloride IV Infusion
Heparin sodium in 0.9% Sodium Chloride infusion is indicated as an anticoagulant in extra corporeal circulation and dialysis procedures and as an aid in the maintenance of catheter patency.It is also indicated for therapeutic treatment of venous thrombosis and thrombosis and thromboemboli in surgical, medical and obstetric patients.Route of administration: Injectable
Molecule: heparin
Patients' opinions on Heparin
In brief
General satisfaction level: Be the first to evaluate
Treatment's effectiveness: Be the first to evaluate
Ease of use: Be the first to evaluate
Adherence to prescription: Be the first to evaluate
Detected side effects: Be the first to evaluate
Improvement in the quality of life: Be the first to evaluate
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Never
10 = Always
1 = Not at all important
10 = Extremely important
1 = Not at all satisfied
10 = Extremely satisfied
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.